JPRN-UMIN000010510已完成2 期
Phase II clinical trial of hypofractionated radiotherapy using proton beams for prostate cancer - Hypofractionated proton therapy for prostate cancer
Proton Medical Research Center, University of Tsukuba0 个研究点目标入组 102 人开始时间: 2013年4月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •Patients who 1) have lymph node metastasis 2) have distant metastasis 3) severe comcomitant diseases such as active infection, heart failure and myocardial infarction, severe respiratory dysfunction, renal faiure, and uncotrolled diabetes mellitus
研究者
相似试验
已完成
不适用
Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancerProstate cancerJPRN-UMIN000022570Kitasato university55
已完成
不适用
Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancerlocalized prostate cancerJPRN-UMIN000038279agoya City University West Medical Center300
进行中（未招募）
不适用
Phase II study of hypofractionated radio-chemotherapy with gemcitabine plus oxaliplatin for unresectable nonmetastatic locally advanced pancreatic cancer. - IRST 157.01EUCTR2010-020379-22-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
已完成
2 期
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before SurgeryAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8NCT03624478Mayo Clinic25
招募中
3 期
Phase III trial of hypo-fractionated accelerated intensity modulated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed Glioblastoma (HYART-GBM)CTRI/2020/06/025573AIIMS New Delhi